Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Pharmacogenomics, studying genetic variation related to drug response, was established decades ago. Today, performing clinical pharmacogenomics testing has increased, creating great potential to improve patient care. Yet widespread implementation of pharmacogenomics in practice is currently limited, resulting in the “therapeutic odyssey” of patients. Preemptive clinical pharmacogenomics testing prior to the time of prescribing is now emerging as an option that could tailor the pharmacotherapy of patients by increasing drug effectiveness while reducing adverse drug reaction risk.

Original languageEnglish (US)
Pages (from-to)39-41
Number of pages3
JournalClinical pharmacology and therapeutics
Issue number1
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care'. Together they form a unique fingerprint.

Cite this